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Abstract
The capacity of a virus to cross species barriers is determined by the development of bona fide interactions with cellular
components of new hosts, and in particular its ability to block IFN-a/b antiviral signaling. Tioman virus (TioV), a close relative
of mumps virus (MuV), has been isolated in giant fruit bats in Southeast Asia. Nipah and Hendra viruses, which are present in
the same bat colonies, are highly pathogenic in human. Despite serological evidences of close contacts between TioV and
human populations, whether TioV is associated to some human pathology remains undetermined. Here we show that in
contrast to the V protein of MuV, the V protein of TioV (TioV-V) hardly interacts with human STAT2, does not degrade STAT1,
and cannot block IFN-a/b signaling in human cells. In contrast, TioV-V properly binds to human STAT3 and MDA5, and thus
interferes with IL-6 signaling and IFN-b promoter induction in human cells. Because STAT2 binding was previously identified
as a host restriction factor for some Paramyxoviridae, we established STAT2 sequence from giant fruit bats, and binding to
TioV-V was tested. Surprisingly, TioV-V interaction with STAT2 from giant fruit bats is also extremely weak and barely
detectable. Altogether, our observations question the capacity of TioV to appropriately control IFN-a/b signaling in both
human and giant fruit bats that are considered as its natural host.
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Introduction
Paramyxoviridae is a family of viruses with a negative-sense RNA
genome that includes important human pathogens like measles
virus (MeV), human parainfluenza virus type 3 (hPIV3), and
human respiratory syncytial virus (hRSV) [1]. As demonstrated by
phylogenic studies, these human pathogens emerged from
zoonotic events that occurred hundreds or thousands of years
ago [2]. Novel Paramyxoviridae have also emerged recently because
of major ecological changes [3]. Deforestation in tropical areas has
destroyed the natural habitat of fruit bat species, forcing them to
live in the vicinity of human settlements. These close contacts are
responsible, in Southeast Asia and Australia, for the emergence of
highly pathogenic Paramyxoviridae in local human populations such
as Nipah virus [4]. While searching for traces of this virus in urine
samples from giant fruit bats of the Pteropus genus, Kaw Bing Chua
and collaborators have isolated another previously unknown
Paramyxoviridae from Rubulavirus genus that was named Tioman
virus (TioV) [5]. Its negative-sense single-strand RNA genome
encodes for six structural proteins that directly participate in viral
replication and/or particle assembly. In addition, the P locus
encodes for two non-structural proteins, V and W (Figure 1),
which are considered as essential virulence factors by homology
with other rubulaviruses like mumps virus (MuV). Some neutral-
izing antibodies against TioV have been found in serum samples
from local inhabitants, suggesting close contacts with this virus [6].
Nevertheless, and despite its ability to infect human cells in vitro
[5,7], whether TioV is associated to some human pathology
remains undetermined. Furthermore, biochemical and functional
properties of TioV proteins, in particular the two non-structural
factors V and W, remain poorly characterized.
Paramyxoviridae V proteins are potent and multifunctional
inhibitors of type I interferon (IFN-a/b) pathway, which is the
core component of antiviral immune response in mammals [8,9].
First, Paramyxoviridae V proteins interact with two cellular proteins
involved in cytoplasmic sensing of viral RNA molecules, MDA5
and LGP2, and thus impair IFN-a/b expression in infected cells
[10,11,12,13]. In addition, Paramyxoviridae V proteins interfere with
cell signaling downstream of IFN-a/b receptor, but each genus
within the family exhibits specific mechanisms of inhibition [14].
For rubulaviruses, the molecular mechanism underlying the
inhibition of IFN-a/b signaling has been well documented for
parainfluenza virus type 5 (PIV5), mumps virus (MuV) and human
parainfluenza virus type 2 (hPIV2). Once secreted, IFN-a/b bind
to membrane receptor IFNAR1/IFNAR2c, and trigger the
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activation of STAT1 and STAT2 transcription factors that
together induce the expression of a large antiviral gene cluster.
Rubulavirus V proteins inhibit this pathway by interacting and
inducing STAT protein polyubiquitinylation and degradation
through the recruitment of an E3 ubiquitin ligase complex
composed of DDB1, Cul4A and Rbx/Roc1 subunits
[15,16,17,18,19,20,21,22,23,24]. Interestingly, MuV and PIV5 V
proteins require cellular STAT2 as an adaptor to recruit and
eliminate STAT1. In contrast, hPIV2 V protein uses STAT1 as an
adaptor to target STAT2 for degradation (although in some cases
it can directly target STAT1 for degradation) [23,25,26,27]. MuV-
V has also evolved a distinct binding interface to recruit directly
STAT3 for ubiquitination and degradation [28,29], resulting in
the inhibition of IL-6 signaling, another pathway involved in the
host antiviral response. Alike MuV-V, the V protein of TioV
(TioV-V) has been shown to bind MDA5 and LGP2, thus
inhibiting IFN induction by viral RNA molecules [10,13].
However, whether TioV-V is also able to inhibit IFN-a/b
signaling pathway by targeting STAT1/2 proteins for proteasomal
degradation has not been addressed. Surprisingly, preliminary
data obtained from a high-throughput functional screen that we
previously performed suggested that the V protein of TioV is
defective for the inhibition of IFN-a/b signaling [30]. This led us
to study in further details TioV-V capacity to block this signaling
pathway in human cells.
Results
TioV Infection Strongly Induces IFN Signaling in Human
Cells
Previous studies have established the infection of human cells by
TioV [5,7], but whether this induced IFN signaling required
further investigations. We have recently established a HEK-293
cell line with a luciferase reporter gene under control of five IFN-
stimulated response elements (ISRE). This reporter cell line was
used to determine the activation of IFN signaling pathway in
human cells upon TioV infection. In parallel, cells were infected
with measles virus (MeV). Indeed, this virus encodes well-known
virulence factors, including P, V and C proteins, which aim at
controlling IFN signaling induction and antiviral response. The
observation of cytopathic effects and formation of numerous
syncytia at 48 h of culture confirmed cellular infection by TioV
and MeV (Figure 2A). Although MeV-infected cells expressed
moderate levels of luciferase, TioV infection was characterized by
a strong induction of the ISRE-luciferase reporter gene at 48 h
post-infection (Figure 2B), which reflects a potent activation of IFN
signaling. This suggests that TioV is incapable of blocking IFN
signaling, but also fails to control IFN production. Indeed, we
found that UV-inactivated supernatant from TioV-infected HEK-
293 cells strongly induced ISRE-luciferase expression when
applied to fresh reporter cells, whereas supernatant from MeV-
infected cells did not (Figure 2C). This is surprising since TioV-V
protein expression was previously shown to block MDA5 and
RIG-I signaling through interactions with MDA5 and LGP2,
respectively [10,13]. However, many cellular components involved
in viral sensing and IFN production are IFN-inducible. As a
consequence, some defect in TioV-V capacity to block IFN
signaling could translate into a robust expression of IFN at later
time-points of the infection, thus explaining our results [31].
Altogether, these observations motivated the functional analysis of
TioV-V protein and its interactions with the IFN signaling
pathway.
The V protein of TioV is Incapable of Blocking IFN
Signaling in Human Cells
TioV-V was first tested for its ability to block IFN-b signaling
downstream of its receptor, and compared to MuV-V which is
known to block this pathway through STAT2 binding and STAT1
targeting for proteasomal degradation. Plasmids encoding for
MuV-V or TioV-V were co-transfected in HEK-293T human
cells together with an ISRE-luciferase reporter plasmid, and
stimulated after 24 hours with 200 IU/ml of recombinant IFN-b.
TioV-V was unable to impair ISRE activation by IFN-b, whereas
MuV-V efficiently inhibited signal transduction as expected
(Figure 3A). To demonstrate that TioV-V is specifically defective
for this function, we compared MuV-V and TioV-V for their
ability to block IL-6 signaling by using a STAT3-dependent
luciferase reporter gene. Although MuV-V was more efficient than
TioV-V, both viral proteins impaired luciferase expression in IL-6
stimulated cells (Figure 3B). We also compared MuV-V and TioV-
V for their capacity to block IFN-b promoter induction by MDA5
overexpression. As shown in Figure 3C, MuV-V and TioV-V
equally inhibited this pathway in agreement with literature [10].
Altogether, these results demonstrate that both MuV-V and
TioV-V inhibit MDA5-dependent IFN-b induction and IL-6
signaling in human cells whereas cell signaling downstream of
IFN-a/b is only impaired by MuV-V. In addition to V, the P gene
of TioV also encodes for the phosphoprotein P, which is part of
the viral replication complex, and W of which function is
undefined. Although a previous report showed that STAT1 can
be only degraded by the full-length PIV5 V protein, excluding the
involvement of the phosphoprotein P [16], we tested if TioV-P or
TioV-W could substitute for TioV-V and block IFN-a/b
signaling. However, neither TioV-P nor TioV-W inhibited ISRE
activation when stimulating cells with recombinant IFN-b
(Figure 3D). As a control, inhibition of IFN-a/b signaling was
also determined when expressing viral proteins without a N-
terminal 3xFLAG tag to verify that it did not interfere with their
function (Figure 3E). Results obtained confirmed our previous
conclusions, showing that known products of the P gene, and in
particular TioV-V, were unable to block IFN-a/b signaling.
Finally, and because TioV has been previously shown to induce
type III interferons (IFN-ls) in primary bat splenocytes [32], we
determined if TioV-V was capable of blocking this signaling
pathway. Although type III interferons bind a specific membrane
receptor called IFNLR1/IL10R2, which is distinct from IFN-a/b
receptor (IFNAR1/IFNAR2c), these cytokines activate STAT1/2
phosphorylation and induce expression of ISRE-regulated genes
alike IFN-a/b. In our reporter system, recombinant IFN-l only
induced a weak expression of the ISRE-luciferase gene, but this
induction was blocked by MuV-V whereas TioV-V was unable to
Figure 1. The gene P of TioV encodes for three proteins: V, W
and P. Whereas conventional transcription and translation lead to the
expression of TioV-V, co-transcriptional insertion of one G residue at the
editing site by the viral RNA polymerase leads to the expression of a
chimeric protein called W. Insertion of two G residues can also occur
during transcription, thus leading to the expression of the phospho-
protein P.
doi:10.1371/journal.pone.0053881.g001
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do so (Figure 3F). This demonstrated that unlike MuV-V, TioV-V
is incapable of targeting components of both IFN-a/b and IFN-l
signaling pathways.
To further demonstrate that TioV-V is unable to block IFN-a/
b signaling in human cells, we quantified the induction of several
IFN-inducible genes in cells expressing either MuV-V or TioV-V.
HEK293-T cells were transfected with expression plasmids
encoding for TioV-V, MuV-V, TioV-P or TioV-W, and then
stimulated with IFN-b. Expression of eleven IFN-inducible genes,
including IFI27, IFI35, IFI44, IFI6, IFIH1, IFIT1, IFIT3,
IFITM1, ISG15, MX1, and OAS1, was determined by quanti-
tative RT-PCR. As shown in Figure 4, gene expression was
strongly inhibited by MuV-V, whereas TioV-V, TioV-P or TioV-
W had no effect. Altogether, we demonstrated that in contrast to
MuV-V, TioV-V or known products of the P gene like TioV-P
and TioV-W are unable to block IFN-a/b signaling in human
cells. This suggested that TioV-V is deficient for targeting specific
cellular proteins, in particular host factors involved in IFN-a/b
signaling events.
TioV-V and MuV-V both Interact with Human MDA5,
LGP2 and STAT3
The functional study described above was performed in parallel
to a detailed analysis of TioV-V interaction profile with cellular
proteins. First, TioV-V was used as bait in the yeast two-hybrid
system to screen a human spleen cDNA library. The screen was
performed at saturation with a 10-fold coverage of the library
(506106 diploids), and positive yeast colonies growing on selective
medium were analyzed by PCR and sequencing to identify
binding partners of TioV-V (data not shown). Using this protocol,
we identified MDA5, LGP2 and STAT3 as direct interactors of
TioV-V. The interactions with MDA5 and LGP2 were previously
Figure 2. Activation of ISRE-dependent gene expression by MeV or TioV infection. HEK-293 cells stably transfected with an ISRE-luciferase
reporter gene (STING-37 reporter cell line) were infected with MeV or TioV. (A) Bright field microscopy of cell cultures at 48 h post-infection (MOI = 1).
(B) Luciferase expression was determined at 24 h and 48 h post-infection. (C) Culture supernatants from (B) were collected at 48 h post-infection,
clarified by centrifugation, UV-inactivated and added to culture wells containing STING-37 cells. Alternatively, culture medium was supplemented
with increasing doses of recombinant IFN-b. After 24 h, luciferase expression was determined. Luciferase activity in culture supernatants from (B) was
below 1,400 luciferase activity units (data not shown). Experiment was performed in triplicates, and data represent means 6 SD. *indicates that
differences observed between MeV and TioV-infected cells were statistically significant (p-value ,0.01).
doi:10.1371/journal.pone.0053881.g002
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reported [10,13]. In contrast, STAT3 binding is new for TioV-V,
although it was previously described for MuV [23,28,29]. To
validate these interactions in human cells, GST-tagged TioV-V or
MuV-V were co-expressed in HEK-293T cells with expression
vectors encoding 3xFLAG-tagged MDA5, LGP2 or STAT3 and
48 h later, viral proteins were purified with glutathion-sepharose
beads. MDA5, LGP2 and STAT3 co-purified with TioV-V
protein, and results were equivalent to those observed with MuV-
V (Figure 5A, B and C). To further establish the specificity of these
interactions, we determined MDA5, LGP2 and STAT3 binding
either to TioV-W, that shares its N-terminal region with TioV-V,
or to the C-terminal VCT region that is specific of TioV-V.
MDA5 and LGP2 only co-purified with TioV-V or the VCT
region, thus demonstrating that the C-terminal region of TioV-V
was sufficient to mediate these two interactions (Figure 5D and E).
In contrast, STAT3 efficiently co-purified with TioV-V and some
weak interaction was detected with TioV-W (Figure 5F). Thus,
full-length TioV-V was required for a strong interaction with
STAT3. Nevertheless, the weak interaction detected with TioV-W
suggested that the N-terminal region is essential in agreement with
a previous report showing that a single point mutation within the
N-terminal region of MuV-V could prevent STAT3 binding
[23,28,29]. Altogether, binding to MDA5 and STAT3 provide
molecular basis to functional data presented in Figure 3B and 3C.
As Opposed to MuV-V, TioV-V does not Efficiently Bind
STAT2, Fails to Induce STAT1 Degradation, and does not
Impair STAT1 Nuclear Translocation in IFN-b-stimulated
Cells
To block cell signaling downstream of IFN-a/b receptor, MuV-
V relies on direct interactions with STAT2 and DDB1 to recruit
and degrade STAT1 [15,16,17,18,20,21,22,23,24]. Since TioV-V
is unable to impair IFN-a/b signaling in human cells, we tested its
ability to interact with human DDB1 and STAT2. We also tested
TioV-V interaction with STAT1. Indeed, we cannot exclude the
possibility that TioV-V binds directly STAT1 rather than STAT2
alike the V protein of hPIV2. First, GST-tagged TioV-V or MuV-
V were co-expressed in HEK-293T cells with 3xFLAG-tagged
Figure 3. TioV-V inhibits IFN-b promoter activation by MDA5 and IL-6 signaling, but not IFN-a/b signaling. (A) HEK-293T cells were co-
transfected with reporter plasmid pISRE-Luc (300 ng/well), pRL-CMV reference plasmid (30 ng/well), and pCI-neo-3xFLAG expression vectors
encoding for 3xFLAG alone or fused to MuV-V or TioV-V (300 ng/well). After 24 h, recombinant IFN-b was added at 200 IU/ml. After an additional
24 h, relative luciferase activity was determined. (B) HEK-293T cells were co-transfected with reporter plasmid pSTAT3-Luc (300 ng/well), pRL-CMV
(30 ng/well), and expression vectors encoding 3xFLAG-tagged MuV-V or TioV-V (300 ng/well). At 24 h post-transfection, recombinant IL-6 was added
at 10 ng/ml. After an additional 24 h, relative luciferase activity was determined. (C) HEK-293T cells were co-transfected with IFN-b-pGL3 reporter
plasmid (300 ng/well), pRL-CMV (30 ng/well), expression vectors encoding 3xFLAG-tagged MDA5 (300 ng/well) and MuV-V or TioV-V (300 ng/well).
After 48 h, relative luciferase activity was determined. (D) Experiment was performed as in (A), but cells were co-transfected with expression vectors
encoding 3xFLAG-tagged TioV-P or TioV-W. (E) Experiment was performed as in (A), but cells were co-transfected with pCI-neo expression vector,
either empty or encoding untagged MuV-V, TioV-V, TioV-P or TioV-W. (F) Experiment was performed as in (A), but cells were stimulated with
recombinant IFN-l1 at 50 ng/ml. All experiments were performed in triplicates, and data represent means 6 SD. *indicates that differences observed
relative to controls (none) with IFN-b, IL-6, MDA5 or IFN-l were statistically significant (p-value,0.01).
doi:10.1371/journal.pone.0053881.g003
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DDB1. After 48 h, viral proteins were purified with glutathion-
sepharose beads, and 3xFLAG-tagged DDB1 was revealed by
western-blot analysis. As shown in Figure 6A, human DDB1
interacted with MuV-V and TioV-V, suggesting that both viral
proteins can recruit the E3 ubiquitin ligase machinery in human
cells. To further establish the specificity of this interaction, we
determined DDB1 binding either to TioV-W or TioV-VCT as
described above. In agreement with structural data showing that
DDB1 binding peptide is localized within the N-terminal region of
PIV5-V [33,34], TioV-V and TioV-W but not TioV-VCT
interacted with this cellular factor (Figure 6B).
Then, we tested TioV-V binding to human STAT2 and
STAT1. GST-tagged TioV-V or MuV-V were co-expressed in
HEK-293T cells with expression vectors encoding for 3xFLAG-
tagged STAT2 or STAT1. After 48 h, viral proteins were purified
with glutathion-sepharose beads, and 3xFLAG-tagged STAT2 or
STAT1 were revealed by western-blot analysis. As shown in
Figure 7A, TioV-V is severely affected for its capacity to bind
STAT2 when compared to MuV-V. Furthermore, neither TioV-
V nor MuV-V interacted with STAT1 whereas Nipah Virus V
protein (NiV-V) was able to do so as expected (Figure 7B). We also
determined if TioV-V could interact with STAT2 when STAT1
and STAT2 were co-expressed. TioV-V showed no interaction
with STAT1 and some very limited binding to STAT2 as reported
above, whereas no interaction was detected with the GST protein
alone or a control protein corresponding to nsP4 from chikungu-
nya virus (CHIKV) (Figure 7C). In contrast, MuV-V strongly
interacted with STAT2 as expected. In agreement with literature,
analysis of total cell lysates showed that MuV-V expression
induced degradation of 3xFLAG-tagged STAT1 in this system.
Interestingly, this degradation was strictly dependent on STAT2
co-expression (compare cell lysates in Figure 7B and 7C), thus
corroborating reports showing that STAT1 degradation by MuV-
V is dependent on STAT2 binding. In contrast, TioV-V
expression showed no effect on STAT1 or STAT2 expression
levels (Figure 7C). Finally, we determined if this interaction profile
was modified when stimulating IFN signaling with recombinant
IFN-b. As shown in Figure 7C, we did not observe any significant
changes, except that MuV-V now co-purified minimal amounts of
STAT1. This could be explained by the formation of stable
phospho-dependent STAT1/STAT2 dimers that co-purified with
MuV-V.
We then investigated the induction of STAT1 degradation and
the binding of TioV-V or MuV-V to endogenous STAT2. HEK-
293T cells were transfected with expression vectors encoding for
3xFLAG-tagged TioV-V, TioV-P, TioV-W or MuV-V, and
Figure 4. Expression of IFN-inducible genes is impaired by MuV-V but not TioV-V expression. HEK-293T cells were transfected with pCI-
neo-3xFLAG expression vectors encoding for 3xFLAG alone or fused to TioV-V, MuV-V, TioV-P or TioV-W (500 ng/well). 24 h after transfection, cells
were left unstimulated or stimulated with 200 IU/ml of recombinant IFN-b. After 24 h of culture, total RNAs were extracted, and expression levels of
indicated genes were quantified by qRT-PCR. For each gene, data were normalized so that 100% corresponds to cells transfected with pCI-neo-
3xFLAG empty vector and stimulated with recombinant IFN-b (dotted red line). Experiment was performed twice and data represent means 6 SD.
*indicates that differences observed with MuV-V relative to controls cells transfected with 3xFLAG alone and stimulated with IFN-b were statistically
significant (p-value,0.05).
doi:10.1371/journal.pone.0053881.g004
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endogenous STAT1 expression was determined by western-blot
analysis at 48 h post-transfection. Results showed that MuV-V
efficiently induced STAT1 degradation whereas TioV-V, alike
TioV-P or TioV-W, had no effect (Figure 7D). To determine
TioV-V binding to endogenous STAT2, HEK-293T cells were
transfected with expression vectors encoding for 3xFLAG-tagged
TioV-V, MuV-V or CHIKV-nsp4, and tagged viral proteins were
immunoprecipitated with anti-FLAG antibodies conjugated to
sepharose beads. Endogenous STAT2 was found to co-immuno-
precipitate with MuV-V but not TioV-V or control protein nsP4
(Figure 7E).
Finally, we determined if nuclear translocation of STAT1 upon
IFN-b stimulation was impaired by TioV-V expression. To
address this question, we built expression vectors encoding for
Cherry protein alone or fused to TioV-V, MuV-V or NiV-V. We
verified that that Cherry-tagged MuV-V and NiV-V inhibited
ISRE-luciferase induction by recombinant IFN-b, whereas TioV-
V was unable to do so (data not shown). Constructs were
transfected in Vero cells and after 48 hours of culture, cells were
stimulated for 30 min with IFN-b. Vero cells were used because,
in contrast to HEK-293T cells, cytosplamic and nuclear
compartments are clearly distinguished, and STAT1 subcellular
localization is easily visualized by immunostaining and fluores-
cence microscopy. As shown in Figure 8, IFN-b induced STAT1
nuclear translocation in cells expressing either Cherry alone or
fused to TioV-V. This experiment was also performed in HEK-
293T and A549 cells, with the same result (data not shown). In
contrast and as expected, Cherry-tagged MuV-V induced STAT1
degradation as assessed by the negative immunostaining, whereas
Cherry-tagged NiV-V sequestered STAT1 in the cytoplasmic
compartment [35,36]. Thus TioV-V is incapable of blocking
STAT1 nuclear translocation in cells stimulated with IFN-b.
Altogether, this demonstrates that in contrast to MuV-V, TioV-
V is incapable of interacting with STAT2 or STAT1, does not
induce their degradation, and does not prevent STAT1 nuclear
translocation upon IFN-b stimulation. These data provide
molecular basis for the inability of TioV-V to block cell signaling
downstream of IFN-a/b receptor in human cells.
TioV-V Hardly Interacts with STAT2 from Giant Fruit Bat
Although this is clearly not the only parameter involved, it has
been previously shown that STAT2 binding is a host restriction
Figure 5. TioV-V binds MDA5, LGP2, and STAT3. (A–C) HEK-293T cells were co-transfected with expression vectors encoding GST alone or
fused to MuV-V (A–C), TioV-V (A–F), TioV-W (D–F) or TioV-VCT (D–F) (500 ng/well), and pCI-neo-3xFLAG expression vectors (300 ng/well) encoding
for 3xFLAG-tagged human MDA5 (A and D), LGP2 (B and E), STAT3 (C and F). Total cell lysates from transfected cells were prepared at 48 h post-
transfection (cell lysate; middle and lower panels), and protein complexes were assayed by pull-down using glutathione-sepharose beads (GST pull-
down; upper panel). 3xFLAG- and GST-tagged proteins were detected by immunoblotting.
doi:10.1371/journal.pone.0053881.g005
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factor for parainfluenza virus 5 (PIV5), another Paramyxoviridae
belonging to Rubulavirus genus. Indeed, the V protein of PIV5
efficiently binds STAT2 from human and other primates, but fails
to interact with mouse STAT2 so that STAT1 degradation is not
induced and IFN signaling is not blocked [37,38,39,40]. A
recombinant PIV5 expressing a mutant V protein (N100D),
which binds mouse STAT2 and blocks IFN signaling but is still
unable to target STAT1 for degradation, better replicates in
mouse cells [37,38,39]. However, this does not seem sufficient to
provide a selective advantage in vivo [40]. In contrast, it has been
shown that PIV5 replicates much better in mice transgenic for
human STAT2, a model where both STAT2 binding and
induction of STAT1 degradation by the V protein of PIV5 is
restored [39]. Altogether, this illustrates the role of STAT2
binding as host restriction factor.
We thus hypothesized that TioV-V, which failed to bind human
STAT2 (hereafter ‘‘hSTAT2’’), could nevertheless interact with
STAT2 from giant fruit bats of Pteropus genus. This question was
particularly interesting because STAT2 sequence from giant fruit
bats has never been established. TioV was originally isolated from
Pteropus hypomelanus, and virus-specific antibodies were also found
in P. conspicillatus, P. rufus as well as Rousettus madagascariensis
[5,41,42]. Genomic sequence for P. hypomelanus has not been
established yet, but we had the opportunity to access blood
samples from closely related P. rodricensis since a large colony of this
endangered species is maintained in a french zoo at La Palmyre
(Charente-Maritime, France). From total RNA extracts, we were
able to amplify, clone and establish the sequence of STAT2 from
P. rodricensis (PrSTAT2). A draft of Pteropus vampyrus genome has
also been established by the Human Genome Sequencing Center,
the Baylor College of Medicine and the Broad Institute, and is
available on Ensembl database. A prediction for STAT2 sequence
of this species is provided (PvSTAT2; ENSPVAP00000007175),
but required some improvements because sequencing coverage,
accuracy, and gene structure annotation were imperfect. We used
our data from P. rodricensis together with human and other
mammalian sequences to correct and improve the current
prediction for PvSTAT2 (see Material and Methods).
As shown in Figure S1, PrSTAT2 and PvSTAT2 were almost
identical, suggesting that STAT2 sequence is highly conserved
among giant fruit bats of Pteropus genus. We thus tested the
capacity of TioV-V to interact with PrSTAT2. GST-tagged TioV-
V or MuV-V were co-expressed with 3xFLAG-tagged hSTAT2 or
prSTAT2 in HEK-293T cells, and then tested for their ability to
interact by co-affinity purification (Figure 9). TioV-V interaction
with hSTAT2 was extremely weak as previously shown in
Figure 7A. Similar results were obtained when TioV-V interaction
with PrSTAT2 was tested. In contrast, MuV-V showed a strong
capacity to bind hSTAT2, and a significant although weaker
capacity to bind PrSTAT2. This demonstrates that unlike MuV-V,
TioV-V is unable to strongly interact with STAT2 from either
human or giant fruit bats.
Discussion
We started this work showing that TioV infection activates IFN
signaling in human HEK-293 cells. This suggested that TioV is
incapable of blocking IFN signaling, but also fails to control IFN
production. This appears surprising since TioV-V protein
expression was previously shown to control IFN induction by
MDA5 and RIG-I through interactions with MDA5 and LGP2,
respectively [10,13]. Although this will need to be confirmed in
TioV-infected cells, our data also validated TioV-V binding to
MDA5 and LGP2, and its capacity to block IFN-b promoter
induction upon MDA5 overexpression. Nevertheless, IFN secre-
tion by TioV-infected cells could be explained by several non-
exclusive mechanisms. First, inhibition of RIG-I signaling by V
proteins form paramyxoviruses is dependent on LGP2 recruit-
ment, and since levels of this co-factor are rate limiting in HEK-
293 cells, TioV-infection could induce IFN expression because
LGP2 is not sufficiently expressed in these cells [13]. It is also
possible that TioV replication produces such high amounts of a
specific viral PAMP, like defective-interfering RNA genomes, that
Figure 6. TioV-V binds DDB1. (A–B) HEK-293T cells were co-transfected with expression vectors encoding GST alone or fused to MuV-V (A), TioV-V
(A–B), TioV-W (B) or TioV-VCT (B) (500 ng/well), and pCI-neo-3xFLAG expression vectors (300 ng/well) encoding for 3xFLAG-tagged human DDB1 (A–
B). Total cell lysates from transfected cells were prepared at 48 h post-transfection (cell lysate; middle and lower panels), and protein complexes were
assayed by pull-down using glutathione-sepharose beads (GST pull-down; upper panel). 3xFLAG- and GST-tagged proteins were detected by
immunoblotting.
doi:10.1371/journal.pone.0053881.g006
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inhibition by TioV-V is ineffective. In addition, TioV could trigger
IFN expression through viral sensors that are distinct from MDA5
and RIG-I. Finally, and since many cellular components involved
in viral sensing are IFN-inducible, it is possible that small amounts
of IFN produced at initial phases of the infection can translate into
a robust expression of IFN-inducible genes at later time-points if
IFN signaling is not blocked. This is supported by observations
performed on PIV5 mutants (CPI- or rSV5-P/V-CPI-) expressing
a V protein defective for STAT1 degradation and inhibition of
IFN-a/b signaling, but competent for MDA5/LGP2 binding
[43,44]. These mutants were found to induce some more (CPI-) or
much more (rSV5-P/V-CPI-) IFN-a/b than the wild-type virus
[45,46]. Since we now established that TioV-V is unable to block
IFN signaling as well, this clearly parallels our observations on
TioV.
Here, we demonstrate that in contrast to the V protein of MuV,
TioV-V hardly interacts with human STAT2, does not induce
STAT1 degradation and is unable to block signal transduction
downstream of IFN-a/b and IFN-l receptors. However, TioV-V
remains functional regarding other known activities of rubulavirus
V proteins, and besides interactions with MDA5 and LGP2, it was
found to bind DDB1 and STAT3. This later interaction probably
Figure 7. TioV-V fails to interact with human STAT2 and does not induce STAT1 degradation. (A–B) HEK-293T cells were co-transfected
with expression vectors encoding GST alone or fused to MuV-V, TioV-V (A–B) or NiV-V (B) (500 ng/well), and pCI-neo-3xFLAG expression vectors
(300 ng/well) encoding for 3xFLAG-tagged human STAT2 (A) or STAT1 (B). Total cell lysates from transfected cells were prepared at 48 h post-
transfection (cell lysate; middle and lower panels), and protein complexes were assayed by pull-down using glutathione-sepharose beads (GST pull-
down; upper panel). 3xFLAG- and GST-tagged proteins were detected by immunoblotting. (C) HEK-293T cells were co-transfected with expression
vectors encoding GST alone or fused to TioV-V, MuV-V or CHIKV-nsP4 (500 ng/well), and pCI-neo-3xFLAG expression vectors encoding for 3xFLAG-
tagged human STAT1 and STAT2 (150 ng/well of each vector). At 24 h post-transfection, cells were left untreated or stimulated with recombinant
IFN-b at 200 IU/ml. Total cell lysates from transfected cells were prepared at 48 h post-transfection (cell lysate; middle and lower panels), and protein
complexes were assayed by pull-down using glutathione-sepharose beads (GST pull-down; upper panels). 3xFLAG- and GST-tagged proteins were
detected by immunoblotting. Upper and lower panels on top of figure C correspond to short and longer exposures of the same blot, respectively. (D)
HEK-293T cells were transfected with pCI-neo-3xFLAG expression vector (1 mg/well) either empty or encoding for 3xFLAG-tagged TioV-V, MuV-V,
TioV-P or TioV-W. Total cell lysates were prepared at 48 h post-transfection and endogenous STAT1 expression levels were determined by western-
blot analysis. Actin expression was determined and used as a protein extraction and loading control. (E) HEK-293T cells were transfected with pCI-
neo-3xFLAG expression vector (1 mg/well) either empty or encoding for 3xFLAG-tagged TioV-V, MuV-V or CHIKV-nsP4. Total cell lysates were
prepared at 48 h post-transfection, and 3xFLAG-tagged viral proteins were purified using anti-FLAG antibodies conjugated to sepharose beads. Co-
immunopurification of endogenous STAT2 with 3xFLAG-tagged viral proteins was determined by western-blot analysis (top and middle panel,
respectively). Actin expression was determined prior to the immunoprecipitation on total cell lysates and used as a protein extraction control (lower
panel).
doi:10.1371/journal.pone.0053881.g007
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accounts for TioV-V capacity to block IL-6 signaling, although it
was not as efficient as MuV-V to block this signaling pathway.
Conformational constraints and/or a lack of adaptation to human
STAT3 could explain the lower capacity of TioV-V to induce a
functional complex targeting STAT3. In future, further investiga-
tions should establish that IL-6 signaling is actually impaired in
TioV-infected cells.
The observation that TioV-V is unable to block IFN signaling
in human cells is of interest to address ecological and epidemi-
ological questions. Indeed, several viruses from Paramyxoviridae
family originating from giant fruit bats have recently emerged in
human populations in Southeast Asia and Australia, which include
two members of Henipavirus genus, Hendra and Nipah viruses, and
one rubulavirus closely related to Tioman virus called Menangle
virus. The seroprevalence of henipaviruses (Nipah or Hendra
virus) and rubulaviruses (Tioman or Menangle) in giant fruit bats
can be very high (.50%) as assessed by a recent survey in Papua
New Guinea [41]. Although Hendra virus has been responsible for
limited outbreaks in Australian horse farms and few fatal human
cases [47], Nipah virus has killed hundreds of people since 1999,
while spreading from Malaysia to Singapore and Bengladesh [4].
Menangle virus also recently emerged from bats, causing disease
outbreaks in Australian piggeries in 1997 with epidemiological
evidence suggesting that it was responsible for severe flu-like
syndromes in two piggery workers [48]. This illustrates the threat
that bat Paramyxoviridae represent for human populations.
The V proteins of Nipah and Hendra viruses have been shown
to block IFN-a/b signaling in several species including human
[35,36]. Because the V protein is essential for rubulaviruses to
inhibit IFN-a/b signaling [15,16,17,18,19,20,21,22,23,24], it is
surprising that TioV-V is unable to block this pathway in human
cells. Interestingly, the interaction with DDB1 suggests that at
some point TioV-V was capable of targeting STAT1 proteins for
proteasomal degradation but has lost this capacity during
evolution. Alternatively, this interaction is maintained because
TioV-V targets other cellular proteins for degradation. Neverthe-
less, the former hypothesis is further supported by the trace
interaction detected between TioV-V and STAT2. In the future,
the use of point mutants as well as MuV/TioV V chimeric
proteins would be suitable to define amino acid residues in TioV-
V and MuV-V that determine STAT2 binding and inhibition of
IFN-a/b signaling cells. This would greatly help to establish that
Figure 8. TioV-V does not inhibit STAT1 nuclear translocation induced by IFN-b. Vero cells were transfected with 100 ng of each plasmid
encoding Cherry alone or fused to TioV-V, MuV-V or NiV-V. After 48 h of culture, cells were stimulated with IFN-b for 30 min, and STAT1 was labeled
by immunostaining to determine its subcellular localization pattern. Green color corresponds to STAT1 whereas red corresponds to Cherry alone or
Cherry-tagged viral proteins. Data show representative fields for each culture condition, and white arrows indicate cells expressing Cherry or Cherry-
tagged viral proteins. Scale bar = 10 mm.
doi:10.1371/journal.pone.0053881.g008
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Tioman virus has indeed lost its capacity to efficiently bind
STAT2 during evolution because of only few mutations. We also
tested P and W proteins of TioV for the inhibition of IFN-a/b
signaling, but none of these proteins exhibited such an activity
when expressed in human cells. Although TioV could express yet
unidentified viral factors to interfere with IFN-a/b signaling,
in vitro infection experiments described in this report rather suggest
some constitutive defect in the capacity of this virus to block IFN-
a/b signaling in human cells.
Whether TioV is able to block IFN-a/b signaling in bats also
remains a pending question. In this report, we established the
sequence of STAT2 from Pteropus rodricensis, and then demonstrat-
ed that TioV-V is a poor binder of prSTAT2. Since this
experiment was performed in human cells, it is possible that
TioV-V and prSTAT2 failed to interact because bat-specific
factors were missing in this microenvironment. It is also possible
that TioV-V directly interacts with STAT1 from bats alike the V
protein of hPIV2 [23,25,26,27]. In order to determine if TioV-V
can block IFN-a/b signaling in bats, experiments must be
performed in cells isolated from giant fruit bats of Pteropus genus.
Unfortunately, no commercial cell line is currently available and
only one lab in Australia has developed this kind of tool [49].
Using this system, Virtue and collaborators have shown that
interferon production and signaling pathways are antagonized
during henipavirus infection of fruit bat cell lines [50].
Altogether, our observations question the capacity of TioV to
appropriately control IFN-a/b signaling in human and bat cells.
Inhibition of IFN-a/b signaling may not be mandatory for TioV
to be maintained in its natural host population and to infect
human, regardless the induction of a specific pathology. Indeed, it
has been reported that the V protein of human parainfluenza virus
type 4 (hPIV4), a member of Rubulavirus genus infecting human, is
unable to inhibit IFN-a/b signaling in host cells [51]. This natural
defect could account for the fact that hPIV4 infection is less
frequent and pathogenesis is less severe compared to other human
paramyxoviruses [52]. Similarly, a human parainfluenza virus type
2 (hPIV2) with V protein mutations that prevented the virus from
inhibiting IFN-mediated signaling maintained its capacity to
replicate in the respiratory tract of non-human primates [53]. In
both cases, the capacity to block IFN-a/b induction through
interactions with MDA5 and LGP2 probably compensates to some
point for the lack of inhibition downstream of IFN-a/b receptor
and the same could be true for TioV in vivo [54]. However, the
capacity of Paramyxoviridae to target STAT proteins has also been
associated to their replication level in a specific host as
aforementioned for PIV5 infection in mice [37,38,39], but also
to the development of pathology. For example, a recombinant
measles virus that is unable to fully antagonize IFN signaling
cannot control inflammation and is attenuated in rhesus monkeys
[55]. These data demonstrate that in some cases, the ability of
Paramyxoviridae to block this antiviral pathway directly influences
their infectivity, virulence and associated pathogenesis. Since our
findings suggest that TioV is defective for the inhibition of IFN-a/
b signaling at least in human cells, future studies should determine
consequences in terms of infectivity, virulence and pathogenesis.
Materials and Methods
Cell Cultures and Tioman Virus Infection
All cells were maintained in Dulbecco’s modified Eagle’s
medium (DMEM; Gibco-Invitrogen) containing 10% fetal calf
serum (FCS), penicillin, and streptomycin at 37uC and 5% CO2.
Tioman virus derived from bat urine (TioV; kindly provided by
Prof. S.K. Lam, University of Malaya, Malaysia) was produced on
VERO-E6 cells, and titrated by plaque assay using the same cell
line. Measles virus stock (MeV; strain Schwarz) was produced on
VERO cells (ATCC), and titrated by TCID50 on HEK-293T cells
(ATCC).
STING-37 cell line that corresponds to HEK-293 cells was
stably transfected with an ISRE-luciferase reported gene, which
will be described in details elsewhere (Lucas-Hourani M. & al.,
manuscript in preparation). Briefly, the ISRE-luciferase reporter
gene was amplified by PCR from pISRE-luciferase reporter
plasmid (Stratagene, Ref 219089), and inserted in a plasmid
carrying a G418-resistance selection marker. This new plasmid
was transfected in HEK-293 cells (ATCC) and two days later,
culture medium was supplemented with G418 at 500 mg/ml.
Transfected cells were amplified and subsequently cloned by serial
limit dilution. A total of 44 clones were screened for luciferase
expression, and STING-37 clone was selected for its optimal signal
to background ratio when stimulated or not with recombinant
IFN-b.
The stock of TioV used in this study was obtained in the BSL-4
‘‘Jean Me´rieux’’ (Lyon, France) in 2001, since the pathogenicity of
this new virus was not known. Since then, the official classification
has still not being made for this virus in France. According to
current rules in the BSL-4 ‘‘Jean Me´rieux’’, this stock of TioV
cannot be taken out of the BSL-4 and consequently all
experiments with live TioV were performed in these stringent
conditions.
STING-37 cells were trypsinized and infected in suspension
with a MOI of 1 or 0.1 at 37uC in DMEM either with TioV or
Figure 9. TioV-V fails to interact with PrSTAT2. HEK-293T cells
were co-transfected with expression vectors encoding GST alone or
fused to TioV-V or MuV-V (500 ng/well), and pCI-neo-3xFLAG expression
vectors (300 ng/well) encoding for 3xFLAG-tagged STAT2 from human
(hSTAT2) or Pteropus rodricensis (PrSTAT2). Total cell lysates from
transfected cells were prepared 48 h post-transfection (cell lysate;
middle and lower panels), and protein complexes were assayed by pull-
down using glutathione-sepharose beads (GST pull-down; upper panel).
3xFLAG- and GST-tagged proteins were detected by immunoblotting.
doi:10.1371/journal.pone.0053881.g009
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MeV. After 1 h of incubation, cells were centrifuged and the
supernatant was removed. Cells were resuspended in DMEM +5%
FCS and plated in 96-well plates. 48 h later, luciferase activity was
determined by addition of 50 ml/well of Bright-GLO reagent
(Promega) and measured during 0.1 s with a luminometer (Tecan).
Plasmid DNA Constructs
TioV-V (NP_665866), TioV-P (NP_665865), TioV-W
(NP_665867), TioV-VCT (AA 150-228 of TioV-V), MuV-V
(ABG48763, Mumps virus isolate ‘‘Sophie’’, GenBank accession
number: DQ660370) and NiV-V (NP_112023.1) coding sequences
were amplified by RT-PCR (Titan One tube; Roche) from RNA
samples kindly provided by Dr. TF Wild, and cloned into
pDONR207 (Invitrogen) using an in vitro recombination-based
cloning system (Gateway system; Invitrogen) as previously
described [30]. Chikungunya virus (CHIKV) nsP4 construct was
previously described [30]. Corresponding constructs were stored
in ViralORFeome database under reference IDs 493, 768, 842,
819, 217, 840 and 716 for MuV-V, TioV-V, TioV-P, TioV-W,
TioV-VCT, NiV-V and CHIKV-nsP4, respectively. Compared to
reference sequences in GenBank, TioV-P and TioV-W sequences
from TioV strain used in this study showed amino acid mutations
at positions N182S/A202V and M182V/R202W, respectively.
Plasmids containing human STAT1 and STAT2 were previously
described [56] whereas MDA5, LGP2, STAT3, and DDB1 coding
sequences were amplified by PCR from a human spleen cDNA
library (Invitrogen) before cloning into pDONR207 (Invitrogen).
Subsequently, viral or cellular ORFs were transferred by an in vitro
recombination from pDONR207 in different Gateway-compatible
destination vectors (see below) following manufacturer’s recom-
mendation (LR cloning reaction, Invitrogen). To perform yeast
two-hybrid experiments, TioV-V viral ORF was transferred into
pDEST32 (Invitrogen) to be expressed in fusion downstream of
the DNA binding domain of Gal4 (Gal4-DB). In mammalian cells,
GST-tag and 3xFLAG-tag fusions were achieved using pDEST27
(Invitrogen) or pCI-neo-3xFLAG vector, respectively [57]. Ex-
pression of untagged proteins was achieved using a modified pCI-
neo vector (Promega) compatible with the Gateway system (kindly
provided by Dr. Yves Jacob).
DNA fragment encoding for PrSTAT2 was generated from total
RNA purified from Pteropus rodricensis blood. Samples were
obtained as part of a routine medical check up performed on
animals of a bat colony maintained in La Palmyre zoo. Blood
samples were collected by the veterinarian in charge following
appropriate guidelines to minimize animal stress and suffering.
Bats were anesthetized prior to be handled using a mask with
isoflurane at 5% for induction and at 3% for maintenance. Blood
was taken from the median vein with a 23G needle. Total RNA
were purified using the RNeasy Protect Animal Blood Kit
(Qiagen), transcribed into cDNA by RT-PCR, and then cloned
in pDONR207 vector. Once established and deposited in
GenBank (ID: JQ846265), PrSTAT2 sequence was aligned and
compared to PvSTAT2 (Figure S1) sequence prediction available
on Ensembl database (ENSPVAP00000007175). Two peptides of
PrSTAT2 were absent from PvSTAT2: LIWDFSYL (AA 398-405)
and ELKLEPILGP (AA 778-787). Furthermore, PL and NL
residues of PrSTAT2 (AA 754-755 and 774-775) were respectively
replaced by a single T and DQ in PvSTAT2. All these
discrepancies were cleared when Ensembl splicing model for
PvSTAT2 sequence was manually curated for intron-exon
junctions. Besides, four amino acid residues from PrSTAT2 were
either absent (P and G at positions 13 and 850, respectively) or
different (P, E, P and P at positions 28, 837, 843 and 854,
respectively) in PvSTAT2 sequence. However, all six residues are
mostly if not totally conserved in human and other mammals thus
suggesting that differences between PrSTAT2 and PvSTAT2
correspond to sequencing errors in PvSTAT2 due to the low
sequencing coverage of this genome. Finally, only one amino acid
substitution (A183V) likely corresponds to a genuine difference
between PrSTAT2 and PvSTAT2 sequences.
Luciferase Reporter Gene Assay
HEK-293T cells were plated in 24-well plates (26105 cells per
well). One day later, cells were transfected with either IFN-b-
pGL3 (0.3 mg/well; [58]) or pISRE-Luc (0.3 mg/well; Stratagene)
or pSTAT3-Luc plasmids (0.3 mg/well; SABiosciences) together
with pRL-CMV reference plasmid (0.03 mg/well; Promega). Cells
were simultaneously co-transfected with 0.3 mg/well of pCI-neo-
3xFLAG expression vectors encoding 3xFLAG alone or fused to
indicated proteins. Alternatively, cells were co-transfected with
0.3 mg/well of pCI-neo expression vectors encoding indicated
proteins without any tag. Transfections were performed with
either Lipofectamine 2000 (Invitrogen) or JetPrime PEI (Polyplus
transfection). 24 h after transfection, cells were stimulated with
IFN-b (Biosource) at 200 IU/ml, 10 ng/ml of recombinant IL-6
(Miltenyi Biotech) or IFN-l1 at 50 ng/ml (Acris). 24 h later, cells
were lysed, and both firefly and Renilla luciferase activities in the
lysates were determined using the Dual-luciferase Reporter Assay
System (Promega). Reporter activity was calculated as the ratio of
firefly luciferase activity to reference Renilla luciferase activity.
Quantitative RT-PCR Analysis
HEK-293T cells were plated in 24-well plates (26105 cells per
well). One day later, cells were transfected with 0.5 mg/well of
pCI-neo-3xFLAG expression vectors encoding 3xFLAG alone or
fused to indicated proteins. Transfections were performed with
JetPrime PEI (Polyplus transfection). 24 h after transfection, cells
were stimulated with IFN-b (Biosource) at 200 IU/ml. 24 h later,
cells were recovered in PBS and total RNA isolated with the
RNeasy Mini Kit (Qiagen) according to manufacturer’s protocol.
Following elution, RNA yields were evaluated using a Nanodrop
spectrophotometer (Nanodrop technologies).
A two-step qRT-PCR (Taqman technology, Applied Biosys-
tems) was performed to measure transcription levels for 11 genes
of interest (primer references are indicated between brackets):
IFI27 (Hs00271467_m1), IFI35 (Hs00413458_m1), IFI44
(Hs00197427_m1), IFI6 (Hs00242571_m1), IFIH1
(Hs01070332_m1), IFIT1 (Hs01911452_s1), IFIT3
(Hs01922752_s1), IFITM1 (Hs00705137_s1), ISG15
(Hs01921425_s1), MX1 (Hs00895608_m1) and OAS1
(Hs00973637_m1). Expression levels of four housekeeping genes,
including 18S (Hs99999901_s1), GAPDH (Hs99999905_m1),
HPRT1 (Hs99999909_m1) and GUSB (Hs99999908_m1), were
also determined and used as an internal reference controls.
Starting from 1 mg of total RNA, cDNA synthesis was achieved in
20 mL using the SuperScript VILO cDNA Synthesis Kit following
manufacturer’s recommendations (Life Technologies). Quantita-
tive PCR reactions were performed on 0.6 mL of cDNA synthesis
reaction mix using the TaqMan Fast Advanced Master Mix
(Applied Biosystems) on a StepOnePlusTM Real-Time PCR
machine (Applied Biosystems). Results were normalized using
expression levels of the four housekeeping genes.
Yeast Two-hybrid Screening Procedure
Our yeast two-hybrid protocol has been described in details
elsewhere [59]. Briefly, pDEST32 plasmid encoding Gal4-DB
fused to TioV-V was transformed in AH109 yeast strain
(Clontech), and used to screen by mating a human spleen cDNA
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library cloned in the Gal4-AD pPC86 vector (Invitrogen) and
previously established in Y187 yeast strain (Clontech). Yeast cells
were plated on a selective medium lacking histidine and
supplemented with 80 mM 3-amino-triazole (3-AT; Sigma-
Aldrich) to select for interaction-dependent transactivation of
HIS3 reporter gene. AD-cDNAs from [His+] colonies were
amplified by PCR and sequenced to identify the host proteins
interacting with TioV-V.
Co-affinity Purification Experiments and Western Blot
Analysis
To perform co-affinity purification experiments, cloned ORFs
were transferred from pDONR207 to pDEST27 expression vector
(Invitrogen) to achieve GST fusion, and to pCI-neo-3xFLAG
vector for 3xFLAG fusion. Then, tagged proteins were expressed
by transient transfection in HEK-293T cells. Briefly, 56105 HEK-
293T cells were dispensed in each well of a 6-well plate, and
transfected 24 h later with 500 ng of each pDEST27 plasmid
encoding viral ORFs and 300 ng of pCI-neo-3xFLAG vector
containing 3xFLAG-tagged indicated proteins. Two days after
transfection, HEK-293T cells were washed in PBS, then
resuspended in lysis buffer (0.5% Nonidet P-40, 20 mM Tris–
HCl at pH 8, 120 mM NaCl and 1 mM EDTA) supplemented
with Complete Protease Inhibitor Cocktail (Roche). Cell lysates
were incubated on ice for 20 min, then clarified by centrifugation
at 14,0006g for 10 min. For pull-down analysis, 400 mg of protein
extracts were incubated for 1 h at 4uC with 25 ml of glutathione-
sepharose beads (Amersham Biosciences) to purify GST-tagged
proteins. Beads were then washed 3 times in ice-cold lysis buffer
and proteins were recovered by boiling in denaturing loading
buffer (Invitrogen). Purified complexes and protein extracts were
resolved by SDS-polyacrylamide gel electrophoresis (SDS-PAGE)
on 4–12% NuPAGE Bis–Tris gels with MOPS running buffer
(Invitrogen), and transferred to a nitrocellulose membrane.
Proteins were detected using standard immunoblotting techniques.
3xFLAG- and GST-tagged proteins were detected with a mouse
monoclonal HRP-conjugated anti-3xFLAG antibody (M2; Sigma-
Aldrich) and a rabbit polyclonal anti-GST antibody (Sigma-
Aldrich), respectively.
Detection of Endogenous STAT Proteins and co-
immunoprecipitation Experiment
HEK-293T cells were plated in 6-well plates at 56105 cells per
well, and transfected 24 h later with 1 mg of pCI-neo-3xFLAG
expression vector encoding viral ORFs. Two days after transfec-
tion, HEK-293T cells were washed in PBS, then resuspended in
lysis buffer (0.5% Nonidet P-40, 20 mM Tris–HCl at pH 8,
120 mM NaCl and 1 mM EDTA) supplemented with Complete
Protease Inhibitor Cocktail (Roche). Cell lysates were incubated
on ice for 20 min, then clarified by centrifugation at 14,0006g for
10 min, and analyzed by Western-blot for STAT1 expression
using an anti-STAT1 monoclonal antibody at a 1:1000 dilution
(Clone 1, BD Biosciences). To control for protein extraction, b-
actin expression was determined in parallel on the same samples
using an anti-actin monoclonal antibody (Clone AC-15, Sigma-
Aldrich).
For co-immunoprecipiation experiments, 400 mg of protein
extracts were incubated for 1 h at 4uC with 20 ml of sepharose
beads conjugated to M2 anti-3xFLAG monoclonal antibody
(EZview Red anti-FLAG M2 Affinity Gel, Sigma-Aldrich) to
purify 3xFLAG-tagged viral proteins. Beads were then washed 3
times in ice-cold lysis buffer and proteins were recovered by
boiling in denaturing loading buffer (Invitrogen). Purified com-
plexes and protein extracts were resolved by SDS-polyacrylamide
gel electrophoresis (SDS-PAGE) on 4–12% NuPAGE Bis–Tris gels
with MOPS running buffer (Invitrogen), and transferred to a
nitrocellulose membrane. Endogenous STAT2 protein expression
was determined by immunoblotting using an anti-STAT2
monoclonal antibody at a 1:250 dilution (Clone 22, BD
Biosciences). To control for protein extraction, b-actin expression
was determined in parallel on total cell lysates using an anti-actin
monoclonal antibody (Clone AC-15, Sigma-Aldrich).
STAT1 Immunostaining and Subcellular Localization
To perform subcellular localization experiments, cloned ORFs
were transferred from pDONR207 to pmCherry-C1 expression
vector (Clontech) made compatible with Gateway system to achieve
Cherry fusion. Vero cells were plated in poly-L-lysine m-slide 8 well
(Ibidi) at 104 cells/well. After 24 h, cells were transfected with
100 ng of each plasmid using Lipofectamine 2000 following
manufacturer’s recommendations (Invitrogen). After 48 h, cells
were incubated with 500 IU/ml of IFN-b for 30 min at 37uC. Cells
were fixed with PFA 3.2% for 20 min, washed and permeabilized
with PBS+0.05% Triton for 5 min at room temperature. Cells were
incubated overnight at 4uC with PBS+5% goat serum. Immuno-
stainingwas performed for 1 hwithmouse anti-STAT1monoclonal
antibody 9H2 (Cell Signaling) diluted in PBS +5% goat serum at
1:100. Cells were washed and stained with anti-mouse Alexa Fluor
488-conjugated secondary antibody (Invitrogen). Finally, cells were
stained DAPI for 5 min, washed and aqueous mounting medium
was added (Fluoromount, Sigma-Aldrich). Slides were analyzed
with a fluorescence microscope (Leica DM/IRB) using oil immer-
sion and a 406objective.
Supporting Information
Figure S1 Analysis of STAT2 sequences from giant fruit
bats in comparison with other mammals. (A) Amino acid
sequences from PrSTAT2 (established in this study) and PvSTAT2
(both before and after editing; windicates specific positions
discussed in the Material and Methods section) have been aligned
to human, panda, ferret, dog, horse, pig and cow orthologous
sequences. Alignment was performed using CLC Workbench
4.0.1. Mismatch and gaps are indicated by red gradation.
(PDF)
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